Macrolide resistance among invasive Streptococcus pneumoniae isolates.

Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA (2009) 4.61

Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet (2013) 2.63

Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000. Emerg Infect Dis (2003) 1.74

An in vitro microfluidic approach to generating protein-interaction networks. Nat Methods (2008) 1.59

Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother (2003) 1.57

High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob Agents Chemother (2003) 1.50

A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol (2010) 1.39

Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar J (2008) 1.37

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob Agents Chemother (2002) 1.30

In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother (2004) 1.30

The "minimizing antibiotic resistance in Colorado" project: impact of patient education in improving antibiotic use in private office practices. Health Serv Res (2005) 1.25

Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany. Antimicrob Agents Chemother (2003) 1.24

Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol (2005) 1.22

Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible. Antimicrob Agents Chemother (2005) 1.22

Antimicrobial resistance in hospitals: how concerned should we be? CMAJ (2009) 1.16

Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998-2004. BMC Pediatr (2009) 1.12

Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all children. CMAJ (2004) 1.06

Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001. Antimicrob Agents Chemother (2003) 1.04

A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis. Clin Ophthalmol (2007) 1.04

What Is the Clinical Impact of Macrolide Resistance? Curr Infect Dis Rep (2004) 1.00

Properties of novel international drug-resistant pneumococcal clones identified in day-care centers of Lisbon, Portugal. J Clin Microbiol (2005) 0.97

Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001. Emerg Infect Dis (2004) 0.97

Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States. J Infect Dis (2013) 0.96

Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002. Antimicrob Agents Chemother (2005) 0.93

Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (2004) 0.92

Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. Antimicrob Agents Chemother (2005) 0.92

Improving rates of pneumococcal vaccination on discharge from a tertiary center medical teaching unit: a prospective intervention. BMC Public Health (2005) 0.90

Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients. Eur J Clin Microbiol Infect Dis (2004) 0.89

In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis. Antimicrob Agents Chemother (2003) 0.87

Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia. J Emerg Med (2007) 0.86

In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides. Antimicrob Agents Chemother (2003) 0.85

Erythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999-2001. Emerg Infect Dis (2005) 0.85

Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era. Antimicrob Agents Chemother (2011) 0.83

Genotypes and related factors reflecting macrolide resistance in pneumococcal pneumonia infections in Japan. J Clin Microbiol (2007) 0.82

Long-term macrolide therapy in chronic obstructive pulmonary disease. CMAJ (2014) 0.81

Multicentre study of the molecular epidemiology, serotypes and antimicrobial susceptibility patterns of invasive Streptococcus pneumoniae invasive isolated from children in the Ille de France area. Eur J Clin Microbiol Infect Dis (2003) 0.80

Serotype Distribution, Antimicrobial Susceptibility, and Molecular Epidemiology of Streptococcus pneumoniae Isolated from Children in Shanghai, China. PLoS One (2015) 0.79

Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections. Antimicrob Agents Chemother (2003) 0.79

Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000. Antimicrob Agents Chemother (2005) 0.79

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial. BMC Pediatr (2012) 0.79

Antimicrobial resistance of Streptococcus pneumoniae isolates in Athens, Greece. Eur J Clin Microbiol Infect Dis (2005) 0.77

Overview of lower respiratory tract infections: diagnosis and treatment. Ochsner J (2002) 0.76

The Value of Macrolide-Based Regimens for Community-Acquired Pneumonia. Curr Infect Dis Rep (2015) 0.76

Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22. Antimicrob Agents Chemother (2005) 0.75

Activity of daptomycin against recent North American isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (2003) 0.75

Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact? Can J Infect Dis (2002) 0.75

Increase in pneumococcus macrolide resistance, USA. Emerg Infect Dis (2010) 0.75

Antibiotic prescribing: can we make it easier? J Gen Intern Med (2002) 0.75

A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem (1973) 31.32

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res (1989) 22.73

Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell (1981) 20.72

A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell (1983) 20.32

A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46

Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl Microbiol (1972) 13.09

Novel screening procedure for recombinant plasmids. Science (1977) 12.66

Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis (2001) 11.73

Physiological differentiation of viridans streptococci. J Clin Microbiol (1977) 11.17

A polypeptide from tomato leaves induces wound-inducible proteinase inhibitor proteins. Science (1991) 9.18

Meningococcal disease. N Engl J Med (2001) 8.50

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis (2010) 8.37

Presumptive identification of group A, B, and D streptococci. Appl Microbiol (1974) 8.23

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med (2000) 8.05

A small segment of polyoma virus DNA enhances the expression of a cloned beta-globin gene over a distance of 1400 base pairs. Nucleic Acids Res (1981) 7.57

Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53

Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun (1973) 7.01

An outbreak of Legionnaires' disease associated with a contaminated air-conditioning cooling tower. N Engl J Med (1980) 6.64

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med (2000) 6.58

Emergence of drug-resistant pneumococcal infections in the United States. JAMA (1994) 6.29

Direct transfer of cloned genes from bacteria to mammalian cells. Proc Natl Acad Sci U S A (1980) 6.21

A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med (1993) 6.18

Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci. Appl Microbiol (1973) 6.17

Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15

A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene. Nature (1984) 6.05

Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med (1998) 6.03

Presumptive identification of group D streptococci: the bile-esculin test. Appl Microbiol (1970) 6.00

Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A (1997) 5.90

Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71

Molecular analysis of the histone gene cluster of psammechinus miliaris: II. The arrangement of the five histone-coding and spacer sequences. Cell (1976) 5.58

Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry (2007) 5.49

Single-chain antigen-binding proteins. Science (1988) 5.29

Mass psychogenic illness attributed to toxic exposure at a high school. N Engl J Med (2000) 5.25

Genes and spacers of cloned sea urchin histone DNA analyzed by sequencing. Cell (1978) 5.18

The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med (1995) 5.18

A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature (1988) 5.16

Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03

CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev (1989) 5.00

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA (2001) 4.90

Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann Intern Med (1993) 4.88

Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol (1997) 4.78

Innovative communicable disease reporting. HSMHA Health Rep (1971) 4.67

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63

Cell type-specificity elements of the immunoglobulin heavy chain gene enhancer. EMBO J (1987) 4.58

Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol (1995) 4.39

The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37

Polyoma virus DNA replication requires an enhancer. Nature (1984) 4.32

Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol (2003) 4.31

A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research. N Engl J Med (1991) 4.23

Immunization of adults. N Engl J Med (1993) 4.23

The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity. Genes Dev (1987) 4.20

Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J (1992) 4.05

Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. J Infect Dis (1991) 4.00

A membrane-associated form of sucrose synthase and its potential role in synthesis of cellulose and callose in plants. Proc Natl Acad Sci U S A (1995) 3.98

Transcriptional 'enhancers' from SV40 and polyoma virus show a cell type preference. Nucleic Acids Res (1982) 3.94

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis (1999) 3.92

Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science (1994) 3.92

Nonhemolytic group B streptococci of human, bovine, and ichthyic origin. Infect Immun (1973) 3.81

An SV40 "enhancer trap" incorporates exogenous enhancers or generates enhancers from its own sequences. Cell (1984) 3.61

OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts. Nucleic Acids Res (1987) 3.56

A surgeon with AIDS. Lack of evidence of transmission to patients. JAMA (1990) 3.49

National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1988) 3.40

Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis (1992) 3.37

Changing epidemiology of group A streptococcal infection in the USA. Lancet (1990) 3.35

Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). EMBO J (1988) 3.33

Wound botulism associated with black tar heroin among injecting drug users. JAMA (1998) 3.32

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31

Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet (1998) 3.29

The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis (1996) 3.26

Phylogenetic analysis of some Aerococcus-like organisms from clinical sources: description of Helcococcus kunzii gen. nov., sp. nov. Int J Syst Bacteriol (1993) 3.16

Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species. J Clin Microbiol (1984) 3.16

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09

Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother (1974) 3.06

Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA (2004) 3.05

Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev (1988) 3.05

Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05

The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis (1992) 3.04

Integration between primary and secondary services in the care of the severely mentally ill: patients' and general practitioners' views. Br J Psychiatry (1997) 3.02

Rapid penicillinase paper strip test for detection of beta-lactamase-producing Haemophilus influenzae and Neisseria gonorrhoeae. Antimicrob Agents Chemother (1977) 3.02

An outbreak of type A botulism associated with a commercial cheese sauce. Ann Intern Med (1996) 2.98

Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) (1978) 2.98

Rationale and design. PRiSM Psychosis Study I. Br J Psychiatry (1998) 2.98

Evaluation of commercial latex agglutination reagents for grouping streptococci. J Clin Microbiol (1979) 2.95

Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol (1993) 2.94

Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA (2001) 2.93

Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol (2001) 2.92

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med (2000) 2.85

Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis (1996) 2.85

Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85

Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis (1995) 2.80

Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis (1990) 2.80

RNA polymerase II C-terminal domain required for enhancer-driven transcription. Nature (1995) 2.78

Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Diagn Microbiol Infect Dis (1986) 2.77